Purpose: To assess choroidal structural changes in patients with retinal dystrophies using choroidal vascularity index (CVI), a novel optical coherence tomography (OCT) based tool. Methods: This retrospective study included 26 patients with retinal dystrophies (17 with retinitis pigmentosa, four with Stargardt disease, three with cone-rod dystrophy, one each with Best disease and Bietti crystalline dystrophy) and 32 healthy controls. Subfoveal OCT images were used for analysis. Mean CVI was compared between retinal dystrophy and control group, as well as among the retinal dystrophy subgroups. Results: Mean CVI in eyes with retinal dystrophies was 52 AE 9% and it was significantly lower compared to that in normal eyes (70 AE 3%, p < 0.001). The differences among subgroups of retinal dystrophy were not statistically significant (p = 0.084). All types of retinal dystrophy were associated with lower CVI (all p < 0.001), after adjusting for age, gender, visual acuity and duration of symptoms. Older age was also shown to be independently associated with lower CVI (p = 0.012). Gender, visual acuity (VA) and duration of symptoms did not significantly affect CVI. Conclusion: Decreased choroidal vascularity was seen in eyes with retinal dystrophies. (CVI) may be a helpful tool in monitoring choroidal involvement in retinal dystrophies.
Introduction
Retinal dystrophies are a heterogeneous group of inherited retinal diseases and are important causes of vision loss, especially in a paediatric population (Bird 1995) . Retinal dystrophies can be generalized, for example retinitis pigmentosa (RP, rod-cone dystrophy), cone-rod dystrophy and Bietti crystalline dystrophy (BCD), or can be localized to the macula in the form of a macular dystrophy. Some genetically determined disorders, particularly those related to mutation in ABCA4 (Stargardt disease) or PRPH2 can give either a pure macular dystrophy or a more generalized phenotype involving both pan-retinal rod and cone photoreceptors.
Retinitis pigmentosa (RP) is the most common group of retinal dystrophies with many genes currently implicated. The reported prevalence ranged from 1 in 750 to 1000 in rural central India (Nangia et al. 2012) and China (Xu et al. 2006 ) to 1 in 3000-5000 in Europe and United States (Bundey & Crews 1984; Bunker et al. 1984; Haim 2002) . The prevalence of cone-rod dystrophy and BCD was much lower at about 1/10th of that of RP (Mataftsi et al. 2004; Hamel 2007) . Stargardt disease is the most common hereditary macular dystrophy in children, with a prevalence of approximately 1 in 10 000. (Riveiro-Alvarez et al. 2009 ) Best disease is the second common macular dystrophy. Its prevalence ranged from 1 in 10 000 to 20 000 in United States (Dalvin et al. 2017 ) to 1.5 in 100 000 in Denmark (Bitner et al. 2012) .
While the photoreceptor and the retinal pigment epithelium (RPE) are recognized as the main site of pathology in retinal dystrophies, changes in choroidal structure and hemodynamics may also play a role in the pathogenesis of this group of diseases; loss of choriocapillaris was shown in ex vivo human eyes with RP using histopathological analysis (Konieczka et al. 2012) . In vivo hemodynamic measurement using multiple techniques also demonstrated reduced choroidal blood flow in RP (Langham & Kramer 1990; Schmidt et al. 2001; Falsini et al. 2011; Zhang et al. 2013; He et al. 2014; Murakami et al. 2015) . Therefore better knowledge of choroidal structural and functional changes may enhance our understanding of retinal dystrophies and may potentially affect the treatment in the future.
The advent of enhanced depth imaging (EDI) in optical coherence tomography (OCT) has allowed non-invasive, quantitative assessment of the choroid (Spaide et al. 2008) . Choroidal thickness has been the main surrogate marker for choroidal structural changes on OCT. Choroidal thinning was reported in majority of such studies concerning RP (Adhi et al. 2013; Ayton et al. 2013; Dhoot et al. 2013; Sodi et al. 2017) , Stargardt disease (Adhi et al. 2015; Vural et al. 2017) , cone-rod dystrophy (Chhablani et al. 2015; Ayyildiz et al. 2016) , Best disease (Battaglia Parodi et al. 2016 ) and BCD (Miyata et al. 2017 ). However, considering the heterogeneous nature of choroid, it was unclear whether the vascular and stromal components were similarly or differentially affected in a group of patients representing different clinical forms of genetically hetergenous hereditary retinal dystrophies including RP, cone-rod dystrophy, Stargardt disease, Best disease and Bietti crystalline fundus dystrophy.
Recently choroidal vascularity index (CVI) was proposed as a novel OCTbased choroidal vascularity marker (Agrawal et al. 2016b,d) . In this study, we envisage to compare choroidal structural changes measured by CVI in eyes with retinal dystrophies with healthy controls and to determine the correlation between CVI and demographic/clinical factors including age, gender, visual acuity, diagnoses and duration of symptoms.
Materials and Methods
This was a retrospective case-control study with participants recruited from a tertiary eye centre in India between December 2014 and November 2015. Twenty-six (26) patients with a diagnosis of RP, Stargardt disease, conerod dystrophy, Best disease or BCD, and 32 healthy volunteers were included in the study. Subjects with ocular pathologies other than retinal dystrophies were excluded. Subjects were also excluded if they had media opacity, refractive error of less than -6 dioptre sphere or abnormal fixation for example nystagmus. Ethics approval was obtained from the Institutional Review Board and informed consent was obtained from each subject. This study adhered to the tenets of Declaration of Helsinki.
All subjects underwent complete ophthalmic examination which included best corrected VA measured by Log-MAR chart, slit-lamp biomicroscopy, intraocular pressure measured by applanation tonometry and dilated fundus examination. All patients except 3 with RP underwent electroretinogram (ERG) testing. Genotype data were not available for all patients in this study. Patients' demographics data and duration of symptoms if any were also recorded.
Image acquisition
All subjects underwent EDI-OCT scans using Spectralis Ò (Heidelberg Engineering, Vista, CA, USA). The macular region was scanned using a seven horizontal line scan (30°9 5°) centred on the fovea, with 100 frames averaged in each B-scan. Each scan was 8.9 mm in length and spaced 240 lm apart from each other.
Image analysis
The raster scan passing through the fovea was selected for analysis. Image binarization was performed using methods proposed by Sonoda et al. (2014) with modification as previously described (Agrawal et al. 2016b,d) . Briefly, images were processed on ImageJ software (version 1.47; provided in the public domain by the National Institutes of Health, Bethesda, MD, USA; http://imagej. nih.gov/ij/). The OCT scans was first converted to 8-bit images using ImageJ default setting. This was followed by application of Niblack's auto local threshold tool to allow demarcation of choroidal luminal area (LA) and stromal area (SA). Then total choroidal area (TCA) was selected using polygon tool by manual plotting of the upper border marked at the RPE and the lower border marked at the choroid-sclera junction. The entire length of the OCT image was used in the selection of TCA. The image was then converted back to an RGB (red, green, blue) image to allow computation of size of LA by the colour threshold tool. Finally, CVI was calculated as the ratio of LA to TCA.
Image grading was done by one of the authors who was a trained grader and who was masked to the patients' information. Examples of OCT images before and after binarization is illustrated in Fig. 1 .
Statistical analysis
Choroidal vascularity index (CVI) in patients with retinal dystrophies and healthy controls were compared using independent sample t-test and CVI among subgroups of retinal dystrophy were compared using one-way analysis of variance. Multivariate logistic and linear mixed model regression was used to assess different parameters affecting CVI in the retinal dystrophy and control group. (CVI) values dependency between two eyes were adjusted using linear mixed model regression analysis. Statistical analyses were performed using commercial software (SPSS software). A p value of <0.05 was considered statistically significant.
Results
A total of 26 patients with retinal dystrophy and 32 healthy controls were included in this study. The mean age was 32.2 AE 12.9 years in the retinal dystrophy group and 32.0 AE 15.4 years in the control group. The proportion of female subjects was 46.9% in the retinal dystrophy group and 34.6% in the control group. There were no significant differences in the age and gender between the two groups (Table 1) . Retinitis pigmentosa (RP) was the most common diagnosis in the retinal dystrophy group and it was present in 65.4% (17/26) of patients. Stargardt disease, cone-rod dystrophy, Best disease and BCD accounted for the remaining 15.4% (4/26), 11.5% (3/26), 3.9% (1/26) and 3.9% (1/26) of patients in the retinal dystrophy group, respectively (Table 2) .
Both eyes of a patient were included in the analysis if the OCT images were gradable (six eyes with ungradable OCT images were excluded). Therefore the total number of eyes in the retinal dystrophy group was 46 (including 30 eyes with RP, seven eyes with Stargardt disease, five eyes with cone-rod dystrophy, two eyes with Best disease and two eyes with BCD) and that in the control group was 64 ( Table 2 ). The mean CVI in eyes with retinal dystrophy was 52 AE 9%, significantly lower than that in normal eyes (70 AE 3%, p < 0.001). Among the retinal dystrophy subgroups, the mean CVI was 51 AE 9%, 59 AE 3%, 46 AE 10% and 52 AE 11% in eyes with RP, Stargardt disease, conerod dystrophy and others. The differences between retinal dystrophy subgroups were not statistically significant (p = 0.084; Table 2 ).
Multivariate regression adjusted analysis of parameters affecting CVI in both retinal dystrophy and control group was performed (Table 3) . Adjusted effects were obtained using linear mixed effect model. All types of retinal dystrophy in this study were associated with lower CVI (all p < 0.001), after adjusting for age, gender, VA and duration of symptoms. Older age was also shown to be independently associated with lower CVI (p = 0.012). Gender, VA and duration of symptoms did not significantly affect CVI in the multivariate regression analysis. (Henkind & Gartner 1983) . More recently, the advent of in vivo imaging techniques has greatly enhanced our understanding of ocular hemodynamic changes in retinal dystrophies. Decreased choroidal blood flow in eyes with RP was demonstrated using ocular pulse amplitude, (Langham & Kramer 1990; Schmidt et al. 2001) , confocal laser Doppler flowmetry (Falsini et al. 2011) , high-resolution magnetic resonance imaging , colour Doppler imaging (He et al. 2014) , and laser speckle flowgraphy (Murakami et al. 2015) . In addition, hemodynamic disturbance in the choroid was shown to correlate with worse retinal function measured by ERG or perimetry in RP (Langham & Kramer 1990; Falsini et al. 2011; Murakami et al. 2015) . Lower CVI in the RP group as shown in our study is in keeping with above results and supports the concept that choroidal vascular defects can influence the manifestation and progression of RP (Konieczka et al. 2012 ). There remains a lack of data on the ocular hemodynamic changes in the other disorders in this study, and research is warranted to confirm whether choroidal blood flow is similarly compromised in view of the lower CVI in these diseases.
The result of this study supported the use of CVI as a non-invasive biomarker that distinguished retinal dystrophies from healthy controls. Retinal blood vessel oxygen saturation was another non-invasive biomarker in ocular hemodynamics that was shown to have a similar use. In patients with RP, retinal venular and arteriolar oxygen saturation was significantly higher compared to those in controls. Retinal venular oxygen saturation also correlated with measures of functional damage that is full field ERG and electrooculogram in RP (Todorova et al. 2016) . Among the inherited retinal dystrophies, rod-cone dystrophy demonstrated a significant association between retinal venular oxygen saturation, vessel diameter and nerve fibre layer thickness, indicating a metabolic and structural correlation (Bojinova et al. 2017 ). The addition of CVI to these known biomarkers may further increase our understanding of the disease process and potentially enable the acquisition of prognostic * Includes Best disease and Bietti crystalline dystrophy. † p-value <0.001; obtained using independent sample t-test for control and retinal dystrophy groups. ‡ p-value = 0.084; obtained using one-way analysis of variance among four groups of retinal dystrophy. data in individuals at risk of developing retinal dystrophies or in determining progression. Choroidal vascularity index (CVI) is a novel tool in the assessment of choroidal structure in vivo in the era of EDI OCT (Agrawal et al. 2016b,d) . In essence, it describes the proportion of vascular area in the choroid. Because CVI encompasses changes in both the vascular and stromal component of the choroid, it gives unique and additional structural information compared to the commonly reported choroidal thickness. The utility of CVI has been validated in numerous publications. In a large cross-sectional study involving healthy subjects, CVI but not choroidal thickness was shown to be independent from systemic and ocular factors including age, systemic blood pressure, axial length and intraocular pressure, making it a good disease biomarker with less influence by confounding factors. (Agrawal et al. 2016b) In healthy individuals, CVI distribution was also highly consistent in the subfoveal, central submacular and total submacular choroid. ) Lower CVI but similar choroidal thickness was reported in eyes from diabetic patients and eyes with exudative age-related macular degeneration (Tan et al. 2016; Koh et al. 2017; Wei et al. 2017) . Choroidal vascularity index (CVI) was also shown to be useful in monitoring longitudinal choroidal structural change with respect to disease progression or in response to treatment in ocular diseases such as panuveitis (Agrawal et al. 2016d ), Vogt-Koyanagi-Harada disease (Agrawal et al. 2016c) , central serous chorioretinopathy (Agrawal et al. 2016a ) and myopic choroidal neovascularization (Ng et al. 2016) .
The traditional choroidal structural marker, choroidal thickness was more commonly reported in retinal dystrophies. In eyes with RP, majority of studies showed choroidal thinning compared to healthy controls (Adhi et al. 2013; Ayton et al. 2013; Dhoot et al. 2013; Sodi et al. 2017 ) except one in which choroidal thickness was reported to be similar to normal patients (Chhablani et al. 2016) . In majority of these studies, the extent of choroidal thinning was not shown to be correlated with VA or duration of disease (Adhi et al. 2013; Ayton et al. 2013; Chhablani et al. 2016; Sodi et al. 2017 ). In Stargardt disease, two studies reported decreased choroidal thickness (Adhi et al. 2015; Vural et al. 2017) while 1 study reported mildly increased choroidal thickness compared to normal controls (Nunes et al. 2015) . However, it was noted that the small increase in choroidal thickness in the latter study was driven by a single case with markedly thicker choroid. Choroidal thinning was also evident in studies on cone-rod dystrophy (Chhablani et al. 2015; Ayyildiz et al. 2016) and BCD (Miyata et al. 2017) . In Best disease, choroidal thickness varied depending on the disease stage, being higher in the vitelliform/pseudohypopyon stage, thinner in the atrophic stage and similar to normal controls in the previtelliform and vitelliruptive stage (Battaglia Parodi et al. 2016) . Corresponding to the changes in choroid thickness, CVI was reduced in all subgroups of the retinal dystrophies in our study. This suggests choroidal thinning in retinal dystrophies as reported in most of the previous studies, may be a result of a more marked atrophy of the vascular component compared to stroma.
There are several limitations in this study. It was cross-sectional in nature and data of longitudinal choroidal structural changes was not available. Clinical and structural correlation was only performed with VA and duration of symptoms, the latter of which might not be an accurate estimate of disease duration. Association between CVI and markers for retinal function such as ERG and perimetry was not possible due to lack of data. We understand that for many of the retinal dystrophies, the retinal structure and function can be entirely normal for some stages, and more importantly normal for some regions but not for the others. We could not study the regional differences in CVI in different types of retinal dystrophy and CVI at different stages of the disease using our algorithm. This study also had a small sample size for subgroup analysis in Stargardt disease, cone-rod dystrophy, Best disease and BCD and bias could arise due to sampling error. The strengths of this study include standardized data collection and imaging protocol, inclusion of age-and gendermatched control group, and good spread of study subjects in different age groups.
In conclusion, choroidal vascularity appears to be reduced in eyes with inherited retinal disease; CVI may be a helpful tool in the evaluation and monitoring associated choroidal involvement. Based on current evidence, it is likely that choroidal vascular changes contribute to or modify the primary pathology of photoreceptor and RPE dysfunction seen in this group of diseases. Future studies which investigate longitudinal CVI changes and its association with retinal function are warranted to confirm this theory.
